EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

MOTS-c attenuates airway barrier dysfunction in allergic asthma by inhibiting epithelial apoptosis via Nrf2 pathway

Wenlong Zhang, Shengpeng Li, Yanli Zhang, Yaxian Wu, Dan Chen, Qingfeng Pang, Shuguang Han

International Immunopharmacology · 2025-08 · 161 · 115014

DOI: 10.1016/j.intimp.2025.115014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-08. Verfasst von Wenlong Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Jiangnan University Medical Center, 68 Zhongshan Road, Wuxi 2140002, Jiangsu Province, PR China…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Asthma, Epithelial Cells, Respiratory Mucosa. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangsu Provincial Health Commission, Jiangsu Commission of Health, Wuxi Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Allergic asthma (AA), a severe chronic respiratory disease of chronic airway inflammation, is characterized by bronchial epithelial barrier dysfunction. The MOTS-c/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway plays a protective role in various diseases by reducing inflammatory responses. This study aimed to evaluate the effects of MOTS-c on airway epithelial barrier function in AA. METHODS: MOTS-c levels in the serum of patients with asthma and healthy volunteers were measured by ELISA. C57BL/6 and Nrf2-knockout (Nrf2-/-) mice were stimulated with house dust mites (HDM) to establish an asthma model. Lung tissue injury and mitochondrial function were assessed using hematoxylin and eosin, immunofluorescence, and immunohistochemistry staining. BEAS-2B cells were pretreated using 10 μM MOTS-c for 2 h and then treated with HDM (1 μM) for 24 h. The epithelial barrier and mitochondrial function were detected through western blot and real-time quantitative polymerase chain reaction, respectively. RESULTS: MOTS-c levels were lower in the serum of patients with asthma than in that of healthy volunteers. Exogenous supplementation of MOTS-c significantly ameliorated lung tissue damage, inflammation, and oxidative stress caused by HDM. However, MOTS-c reversed the barrier function and mitochondrial damage in AA mice. Furthermore, MOTS-c significantly inhibited inflammation, oxidative stress, and mitochondrial damage in HDM-stimulated BEAS-2B cells. Mechanistically, MOTS-c attenuates airway barrier damage in AA by inhibiting bronchial epithelial apoptosis via the Nrf2 pathway. CONCLUSION: MOTS-c alleviated AA by attenuating airway barrier dysfunction through an Nrf2-dependent mechanism. Therefore, MOTS-c may potentially act as a novel protective agent against AA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2AsthmaEpithelial CellsRespiratory MucosaAnimalsHumansApoptosisMice, Inbred C57BLMaleMiceFemaleSignal TransductionMice, KnockoutCell LineAdultPyroglyphidaeDisease Models, AnimalMiddle AgedOxidative StressLungMitochondria

Stichwörter der Autor:innen

Allergic asthmaChronic airway inflammationEpithelial cellsMitochondrial damage

Substanzen

NF-E2-Related Factor 2NFE2L2 protein, humanNfe2l2 protein, mouse

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Jiangnan University Medical Center, 68 Zhongshan Road, Wuxi 2140002, Jiangsu Province, PR China; Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi…
  • Wuxi School of Medicine, Jiangnan University, 1800 Lihu Avenue, Wuxi 214122, Jiangsu Province, PR China.
  • Department of Respiratory and Critical Care Medicine, Jiangnan University Medical Center, 68 Zhongshan Road, Wuxi 2140002, Jiangsu Province, PR China.

Förderung

  • Jiangsu Provincial Health Commission
  • Jiangsu Commission of Health
  • Wuxi Health Commission

Zitieren

APA

Zhang, W., Li, S., Zhang, Y., Wu, Y., Chen, D., Pang, Q., & Han, S. (2025). MOTS-c attenuates airway barrier dysfunction in allergic asthma by inhibiting epithelial apoptosis via Nrf2 pathway. International Immunopharmacology, 161, 115014. https://doi.org/10.1016/j.intimp.2025.115014

Vancouver

Zhang W, Li S, Zhang Y, Wu Y, Chen D, Pang Q, et al. MOTS-c attenuates airway barrier dysfunction in allergic asthma by inhibiting epithelial apoptosis via Nrf2 pathway. International Immunopharmacology. 2025;161:115014. doi:10.1016/j.intimp.2025.115014

BibTeX
@article{Zhang2025,
  author = {Zhang, Wenlong and Li, Shengpeng and Zhang, Yanli and Wu, Yaxian and Chen, Dan and Pang, Qingfeng and Han, Shuguang},
  title = {MOTS-c attenuates airway barrier dysfunction in allergic asthma by inhibiting epithelial apoptosis via Nrf2 pathway},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {161},
  pages = {115014},
  doi = {10.1016/j.intimp.2025.115014}
}
Kostenlos starten →